About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials | 4,040 Studies Recruiting

Clinical TrialsOvarian Cancer

Ovarian Cancer Clinical Trials

Browse 4,040 clinical trials for ovarian cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3341-3360 of 4,040 trials

CompletedErlotinib Plus Carboplatin and Paclitaxel in Ovarian CarcinomaThis phase II trial is studying the side effects of giving erlotinib together with carboplatin and paclitaxel and to see how well it works in treating patients with stage III or…NCT00059787·The Bronx, New York CompletedLymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell TransplantationRATIONALE: White blood cells from donors may be able to kill cancer cells in patients with cancer that has recurred following bone marrow or peripheral stem cell transplantation.NCT00003887·Seattle, Washington TerminatedA Safety and Tolerability Study of NC410 in Subjects With Advanced or Metastatic Solid TumorsThis research study is studying a new drug, NC410, as a possible treatment for advanced or metastatic solid tumors.NCT04408599·Bethesda, Maryland and 4 others

Related Searches

ovary cancertrials

Data from ClinicalTrials.govTerms

RecruitingPersonalized Timing of Interval Debulking Surgery in Advanced Ovarian CancerAbout 70% of epithelial ovarian cancer patients are diagnosed at advanced stage.NCT07023484·Guangzhou and 5 others

CompletedFrench Observatory of Rare Malignant Tumors of the OvaryTo take charge of the treatment in rare adult ovarian tumors with an homogenous manner (germinal and sexual cords tumors), at different stages of the disease.NCT01304043·Paris

TerminatedVaccine Therapy, Paclitaxel, and Carboplatin in Treating Patients Who Are Undergoing Surgery for Stage III or Stage IV Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerRATIONALE: Vaccines made from peptides may help the body build an effective immune response to kill tumor cells.NCT00373217·Charlottesville, Virginia

CompletedEsketamine for Prevention of Depression After Cytoreductive Surgery in Ovarian CancerThe goal of this clinical trial is to learn if intraoperative administration of esketamine would prevent or mitigate postoperative depressive symptoms after cytoreductive surgery…NCT06624878·Hangzhou, Zhejiang

TerminatedBrUOG 390: Neoadjuvant Treatment With TalazoparibOvarian cancer is the most fatal gynecologic cancer; in the US alone an estimated 22,000 women will be diagnosed in 2019, with over 13,000 dying of the disease.NCT04598321·Providence, Rhode Island and 1 other

TerminatedCarboplatin Plus Docetaxel With Day 2 Pegylated G-CSF (Neulasta®) in Patients With Advanced Stage Ovarian CarcinomaIn this study the investigators will be using an AUC of 6 based on creatinine clearance using the Carboplatin dosing formula used for Gynecologic Oncology Group protocols.NCT02469116·St Louis, Missouri

TerminatedEfficacy of Letrozole in Recurrent Ovarian CancerRandomized phase III multicenter study investigating the role of letrozole in heavily pretreated recurrent ovarian cancer.NCT04421547·Roma

WithdrawnInfluence of Chemotherapy on Gamma-delta T Cells in Patients With Epithelial Ovarian CancerIn patients with an ovarian cancer, the treatment is currently based on surgery and chemotherapy.NCT01606358·Rennes

CompletedStudy of Circulating Tumoral DNA in Ovarian CancerCirculating tumor DNA detection and quantification in patients with ovarian cancer.NCT01350908·Paris

CompletedCombination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell TumorsRATIONALE: Drugs used in chemotherapy, such as paclitaxel, ifosfamide, carboplatin, and etoposide work in different ways to stop the growth of tumor cells, either by killing them…NCT00002558·New York, New York

Active not recruitingA Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid TumorsThe main purpose of the study is to assess whether the study drug, LY4066434, is safe and tolerable when administered to participants with locally advanced or metastatic solid…NCT06607185·Birmingham, Alabama and 44 others

RecruitingSY001 Targets Mesothelin in a Single-arm, Dose-increasing Setting in Subjects With Advanced Solid TumorsSingle-arm, dose-increasing setting study of CAR macrophages in Mesothelin overexpressing solid tumors.NCT06562647·Hangzhou, Zhejiang and 1 other

UnknownPDL-1 Inhibition and Focal Sensitizing Radiotherapy in Recurrent Ovarian/Primary Peritoneal/Fallopian Tube Cancers.It is postulated that focal sensitizing radiotherapy may potentiate the effectiveness of durvalumab.NCT03283943·Vancouver, British Columbia

RecruitingTorvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Homologous Recombination Deficiency (HRD) Negative Advanced Epithelial Ovarian CancerThis study will evaluate the efficacy, safety and tolerability of Torvutatug samrotecan (torvu-sam) in combination with bevacizumab compared with bevacizumab monotherapy as first…NCT07851025·Tampa, Florida and 185 others

CompletedMirvetuximab Soravtansine and Gemcitabine Hydrochloride in Treating Patients With FRalpha-Positive Recurrent Ovarian, Primary Peritoneal, Fallopian Tube, Endometrial, or Triple Negative Breast CancerThis phase I trial studies the side effects and best dose of mirvetuximab soravtansine and gemcitabine hydrochloride in treating patients with folate receptor (FR) alpha-positive…NCT02996825·Duarte, California and 1 other

CompletedTLK286 in Combination With Paraplatin (Carboplatin) in Recurrent Ovarian CancerThis is a dose-ranging, open label, Phase 1-2a study of TLK286 in combination with Paraplatin (carboplatin) in patients with recurrent ovarian cancer.NCT00051948·Santa Monica, California and 5 others

CompletedCombination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell TumorsRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00002489·New York, New York

PreviousPage 168 of 202Next